Oscillo Biosciences is a pre-commercial biotech company developing medical devices and digital therapeutic platforms to treat serious neurodegenerative diseases like Alzheimer's Disease, Parkinson's, aphasia, dyslexia and others. More than 6 million Americans suffer from dementia due to Alzheimer’s disease, and the incidence is rising at an alarming rate. Alzheimer’s disease is the 5th leading cause of death among Americans age 65 and older. Among the top 10 causes of death, it is the only one for which there is no known cure. Our approach is predicated on the understanding that brain rhythms supporting memory and cognition are disrupted in people with Alzheimer’s disease. Recent studies have proven that stimulating brain waves at specific frequencies can bring about changes at the molecular level, diminishing brain plaques, untangling neural networks, and improving memory and cognition. We are currently developing a prescription medical device and digital therapeutic that work together to restore healthy brain function in patients with Mild Cognitive Impairment and Alzheimer’s disease.